Neurology

We have adapted advanced, multi-spectral statistical classification algorithms to create highly reproducible tissue identification, registration, and analysis applications for brain structures. When coupled with our expert readers, these systems allow the quantification of endpoints such as brain volume and lesion burden with both accuracy and precision. We have extensive experience in generating imaging endpoints for multiple sclerosis, Alzheimer's disease, and cancers of the brain.

Here is a sample of the biomarkers we measure in Neurological diseases:

• Brain, WM/GM Volume, brain parenchymal fraction (BPF)
• Track brain atrophy seen in MS, AD, etc.
• MS Lesion Burden, a primary imaging marker for MS.
• Hippocampal volume, reflects changes seen in AD, epilepsy